PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,177 | +1.7% | 19,247 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $116,198 | +37.0% | 18,562 | +4.4% | 0.00% | 0.0% |
| Q1 2023 | $84,787 | -44.1% | 17,775 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $151,563 | -27.1% | 17,421 | -0.4% | 0.00% | -50.0% |
| Q3 2022 | $208,000 | -15.4% | 17,485 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $246,000 | -9.2% | 17,237 | +32.4% | 0.00% | +100.0% |
| Q1 2022 | $271,000 | -15.8% | 13,023 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $322,000 | -24.8% | 13,939 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $428,000 | -14.7% | 14,357 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $502,000 | +91.6% | 14,698 | +84.6% | 0.00% | +100.0% |
| Q1 2021 | $262,000 | -46.3% | 7,963 | +0.3% | 0.00% | -50.0% |
| Q4 2020 | $488,000 | – | 7,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |